Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04874207 |
| Title | Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib (RePERSO) |
| Acronym | RePERSO |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Rennes University Hospital |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| CHU Caen | Caen | France | Details | |||
| AP-HP Henri Mondor | Créteil | France | Details | |||
| Institut Daniel Hollard, Groupe Hospitalier Mutualiste de Grenoble | Grenoble | France | Details | |||
| CHU Nantes | Nantes | France | Details | |||
| AP-HP St Antoine | Paris | France | Details | |||
| Centre Eugène Marquis | Rennes | France | Details | |||
| CHU Rennes | Rennes | France | Details | |||
| CHU Rouen | Rouen | France | Details | |||
| CHU Tours | Tours | France | Details |